Chengdu Olymvax Biopharmaceuticals Inc.

XSSC:688319 Stock Report

Market Cap: CN¥4.8b

Chengdu Olymvax Biopharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Shaowen Fan

Chief executive officer

CN¥713.5k

Total compensation

CEO salary percentagen/a
CEO tenure14.8yrs
CEO ownership3.9%
Management average tenureno data
Board average tenure8.4yrs

Recent management updates

Recent updates


CEO

Shaowen Fan (71 yo)

14.8yrs

Tenure

CN¥713,500

Compensation

Mr. Shaowen Fan is Chairman of the Board & GM of Chengdu Olymvax Biopharmaceuticals Inc. from January 2010. Mr. Fan joined the Chengdu Olymvax Biopharmaceuticals Inc. in 2010.


Board Members

NamePositionTenureCompensationOwnership
Shaowen Fan
Chairman of the Board & GM14.8yrsCN¥713.50k3.86%
CN¥ 183.8m
Yunhui Yu
Director11.4yrsCN¥42.00k0.014%
CN¥ 657.1k
Pengfei Zhang
Chairman of Supervisory Board8.4yrsno data6.38%
CN¥ 303.7m
Fan Fan
Executive Deputy GM & Vice Chairman of the Board14.8yrsCN¥633.20k7.53%
CN¥ 358.6m
Cheng Hu
Director2.5yrsCN¥42.00k1.64%
CN¥ 78.2m
Aimin Chen
Director14.8yrsCN¥602.00k0.15%
CN¥ 7.2m
Lu Lu
Employee Representative Director2.5yrsCN¥195.00k0.067%
CN¥ 3.2m
Shao Ping He
Independent Director5.6yrsCN¥83.90kno data
Hua Yan
Supervisor2.5yrsno data0.20%
CN¥ 9.6m

8.4yrs

Average Tenure

61yo

Average Age

Experienced Board: 688319's board of directors are considered experienced (8.4 years average tenure).